All posts by medical

Study: People who felt their life was guided by meaningful values or goals were more willing to engage in COVID-19 protective behaviors – YubaNet

Why can some people weather the stress of social isolation better than others, and what implications does this have for their health? New research from the Communication Neuroscience Lab at the Annenberg School for Communication at the University of Pennsylvania found that people who felt a strong sense of purpose in life were less lonely during the COVID-19 pandemic. Did they achieve less loneliness by flouting public health guidance? No. Although lonelier people were less likely to want to follow public health guidance, people with a stronger sense of purpose also expressed more willingness to engage in social distancing, hand washing, and other COVID-19 protective behaviors.

Purpose in life, or a sense that your life is guided by personally meaningful values and goals which could involve family ties, religion, activism, parenthood, career or artistic ambitions, or many other things has been associated in prior research with a wide range of positive health outcomes, both physical and psychological.

In the face of adversity, people with a stronger sense of purpose in life tend to be more resilient because they have a clear sense of goals that motivate actions that are aligned with personal values, says Yoona Kang, Ph.D., lead author and a Research Director of the Communication Neuroscience Lab. People with strong purpose may also experience less conflict when making health decisions. We felt that the COVID-19 pandemic was an important context to test whether purpose in life relates to individuals willingness to engage in behaviors to protect themselves and others.

Based on their prior research, Kang and her collaborators expected that people with higher sense of purpose would be more likely to engage in COVID-19 prevention behaviors than individuals with a lower sense of purpose. In order to test their theory, the researchers surveyed more than 500 adult participants to capture their levels of purpose in life, their current and pre-pandemic levels of loneliness, and the degrees to which they intended to engage in behaviors known to prevent the spread of COVID-19.

They found that higher levels of loneliness made people be less focused on protecting themselves from COVID-19, and more skeptical that behaviors to prevent COVID-19 would be effective. However, having a stronger sense of purpose was associated with lower levels of loneliness and a greater desire to take action to protect themselves from COVID-19. Those with a higher sense of purpose also expressed a stronger belief that COVID-19 prevention behaviors would work. Even when people who had a strong sense of purpose did report being lonely, they still felt strongly about taking precautions to prevent COVID-19.

When faced with extreme loneliness and social isolation, like during the COVID-19 pandemic, wanting to connect with other people, despite the health risks, is a natural response, Kang says. And yet, amidst this drastic shift in social life, we found that people with a higher sense of purpose were more likely to engage in prevention behaviors. This is striking because it shows that purpose in life can empower people to make life-saving health decisions that protect their own health and those around them.

Additionally, the researchers found that older people expressed less loneliness during the COVID-19 pandemic than younger people. Kang sees this as a sign of the resilience of older adults, and she hopes to further study how to enhance purpose in life and resilience in aging populations.

Having a stronger sense of purpose was associated with really important, positive outcomes across the lifespan, says Emily Falk, senior author, Director of the Communication Neuroscience Lab, and Professor of Communication, Psychology, and Marketing. Our upcoming work will test interventions to increase their sense of purpose, in hopes of bringing these benefits to more people.

The study, published yesterdayinThe Gerontologist, is entitled Purpose in Life, Loneliness, and Protective Health Behaviors during the COVID-19 Pandemic, and is available here.In addition to Kang and Falk, authors include Danielle Cosme, Ph.D.; Rui Pei, Ph.D.; Prateekshit Pandey; and Jos Carreras-Tartak.

Continued here:
Study: People who felt their life was guided by meaningful values or goals were more willing to engage in COVID-19 protective behaviors - YubaNet

Here’s how stress during coronavirus pandemic linked to poor sleep – Hindustan Times

The findings of a study on hundreds of twins led by Washington State University researchers suggest that stress, anxiety and depression during the first few weeks of the pandemic were associated with less and lower quality sleep.

The study was published in Frontiers in Neuroscience. In a survey of more than 900 twins taken shortly after COVID-19 lockdown measures began, about half of the respondents reported no change in their sleep patterns, but around a third, 32.9 per cent, reported decreased sleep.

Another 29.8 per cent reported sleeping more. In the analysis, the researchers found that any change in sleep was connected to self-reported mental health issues, though it was more strongly associated with decreased sleep.

"The results show that deviations from your typical sleep behavior may be associated with depression, anxiety and stress," said Siny Tsang, lead author on the study published in Frontiers in Neuroscience.

Tsang, a staff scientist with the WSU Elson S. Floyd College of Medicine, emphasized that this showed a connection, not a cause, but the study supports previous research that has found a two-way relationship between disrupted sleep patterns and poor mental health.

In other words, when people don't sleep well, they are more likely to feel stress, anxiety and depression, and when they are dealing with those same problems, they are more likely to sleep less--and sometimes more--than the typical six to nine hours a night.

This study analyzes survey responses collected between March 26 and April 5, 2020, from participants in the Washington State Twin Registry. Since then, the same group has answered three more waves of survey questions.

Researchers are particularly interested in studying twins, so they can investigate whether associations are mediated by genetic factors, shared environment, or both. The pandemic also offered an opportunity for a natural experiment to see how a stressful situation affects sleep amount and quality among individuals in the community, Tsang said.

The research relies on the self-reported perception of sleep length and quality, but the researcher said that when it comes to mental health, perception can matter more than the real amount of sleep.

"Even if your cell phone says you consistently sleep eight hours every day, you may feel that you slept less or slept poorly, and that may be linked to stressful or anxious feelings," Tsang said. "It may not matter whether or not the actual number has changed. It's how you are feeling that is associated with your mental health."

WSU researchers have also conducted twin studies on COVID-19 lockdown effects on alcohol use and pandemic stress and exercise. These have all been initial studies taken at the early stages of the pandemic and associated social distancing measures. The scientists are still analyzing the results of later surveys, but they are starting to see a common theme.

"A pattern that is consistent across these three studies is that people who reported change in physical exercise, alcohol use or sleep are more stressed, anxious and depressed than those who had said that they have had no change," Tsang said.

Go here to see the original:
Here's how stress during coronavirus pandemic linked to poor sleep - Hindustan Times

Zhongchao Inc. Partners with a Subsidiary of AbbVie Inc. (NYSE: ABBV) for Medical Education Services – BioSpace

SHANGHAI, June 16, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering online healthcare information, professional training and educational services, today announced the cooperation in physician education with AbbVie Pharmaceutical Trading (Shanghai) Co., Ltd. ("AbbVie Shanghai"), a subsidiary of AbbVie Inc (NYSE: ABBV) ("AbbVie"). AbbVie is a research-based global biopharmaceutical company. Pursuant to an agreement to facilitate such cooperation, Zhongchao and AbbVie Shanghai will cooperate in, including but not limited to, developing the medical education contents and producing medical education courses.

Weiguang Yang, Chairman and Chief Executive Officer of Zhongchao, commented, "AbbVie is one of the top ten global research-oriented biopharmaceutical companies with numerous innovations in the core field of immunology, oncology, neuroscience, and Allergan Aesthetics. In recent years, AbbVie has introduced more and more innovative therapies and drugs to the Chinese market, benefitting Chinese patients. We are honored to cooperate with AbbVie Shanghai to promote the development of medical education."

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. They strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit http://www.abbvie.com.

About Zhongchao Inc.

Incorporated in 2012 with headquarter offices in Shanghai and Beijing, China, Zhongchao Inc. is an online provider of healthcare information, professional training and educational services to healthcare professionals under its "MDMOOC" platform (www.mdmooc.org) and to the public under its "Sunshine Health Forums" platform (www.ygjkclass.com) in China. More information about the Company can be found at its investor relations website at http://izcmd.com.

Safe Harbor Statement

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's goals and strategies; the Company's future business development; product and service demand and acceptance; changes in technology; economic conditions; the growth of the professional training and educational services market in China and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in China and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC, the length and severity of the recent coronavirus outbreak, including its impacts across our business and operations. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, which are available for review at http://www.sec.gov. The Company undertakes no obligation to publicly revise these forwardlooking statements to reflect events or circumstances that arise after the date hereof.

For more information, please contact:

At the Company: Pei Xu, CFOEmail: xupei@mdmooc.orgPhone: +86 21-3220-5987

Investor Relations: Sherry ZhengWeitian Group LLCEmail: shunyu.zheng@weitian-ir.comPhone: +1 718-213-7386

View original content:http://www.prnewswire.com/news-releases/zhongchao-inc-partners-with-a-subsidiary-of-abbvie-inc-nyse-abbv-for-medical-education-services-301313255.html

SOURCE Zhongchao Inc.

Company Codes: NASDAQ-NMS:ZCMD

View original post here:
Zhongchao Inc. Partners with a Subsidiary of AbbVie Inc. (NYSE: ABBV) for Medical Education Services - BioSpace

BioXcel Therapeutics to Host Virtual Commercial Day on June 25, 2021Live webcast to be held on June 25th from 12:00 PM ET 1:30 PM ET – BioSpace

NEW HAVEN, Conn., June 18, 2021 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. ("BioXcel" or the "Company") (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that the Company will host a virtual Commercial Day on Friday, June 25, 2021, from 12:00 PM ET 1:30 PM ET.

The event aims to provide an update on the Companys launch readiness plans and market insights for BXCL501, an investigational, proprietary, orally dissolving thin film formulation of dexmedetomidine for the acute treatment of agitation associated with schizophrenia and bipolar disorders I and II in adults, along with a key opinion leader clinical perspective.

Vimal Mehta, Ph.D., Chief Executive Officer, and Will Kane, Chief Commercial Officer, will be joined by members of the Companys commercial leadership team, as well as industry expert, Dr. Leslie S. Zun, Professor of Emergency Medicine at Chicago Medical School.

A live webcast of the event and the accompanying presentation materials will be accessible through the investors section of the Companys website at http://www.bioxceltherapeutics.com on June 25th at 12:00 PM ET. Following the event, the webcast will be archived on the Companys website for at least 30 days.

About BXCL501

BXCL501 is an investigational, proprietary, orally dissolving thin film formulation of dexmedetomidine, a selective alpha-2a receptor agonist for the treatment of agitation and opioid withdrawal symptoms. BioXcel believes that BXCL501 potentially targets a causal agitation mechanism, and the Company has observed anti-agitation results in multiple clinical studies across several neuropsychiatric disorders, including schizophrenia related agitation (SERENITY I), bipolar disorder related agitation (SERENITY II) and dementia related agitation (TRANQUILITY). BXCL501 has been granted Breakthrough Therapy designation for the acute treatment of agitation associated with dementia and Fast Track designation for the acute treatment of agitation associated with schizophrenia, bipolar disorders and dementia. The Company recently received acceptance of its New Drug Application for BXCL501 for the acute treatment of agitation associated with schizophrenia and bipolar disorders. The safety and efficacy of BXCL501 has not been established.

About BioXcel Therapeutics, Inc.

BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. BioXcels drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. BioXcels two most advanced clinical development programs are BXCL501, an investigational, proprietary, orally dissolving thin film formulation of dexmedetomidine for the treatment of agitation and opioid withdrawal symptoms, and BXCL701, an investigational, orally administered, systemic innate immunity activator in development for the treatment of aggressive forms of prostate cancer and advanced solid tumors that are refractory or treatment nave to checkpoint inhibitors. For more information, please visit http://www.bioxceltherapeutics.com.

Contact Information:

BioXcel Therapeutics, Inc.www.bioxceltherapeutics.com

Investor Relations:Mary ColemanBioXcel Therapeutics, VP of Investment RelationsMColeman@bioxceltherapeutics.com1.475.238.6837

John GrazianoSolebury Troutjgraziano@soleburytrout.com1.646.378.2942

Media:

Julia DeutschSolebury Troutjdeutsch@soleburytrout.com1.646.378.2967

The rest is here:
BioXcel Therapeutics to Host Virtual Commercial Day on June 25, 2021Live webcast to be held on June 25th from 12:00 PM ET 1:30 PM ET - BioSpace

Depression, anxiety during pandemic linked to poor sleep – Devdiscourse

Anxiety and depression during the first few weeks of the pandemic were associated with less and lower quality sleep, as per the findings of a study conducted on hundreds of twins led by Washington State University researchers. The study was published in Frontiers in Neuroscience. In a survey of more than 900 twins taken shortly after COVID-19 lockdown measures began, about half of the respondents reported no change in their sleep patterns, but around a third, 32.9 per cent, reported decreased sleep.

Another 29.8 per cent reported sleeping more. In the analysis, the researchers found that any change in sleep was connected to self-reported mental health issues, though it was more strongly associated with decreased sleep. "The results show that deviations from your typical sleep behavior may be associated with depression, anxiety and stress," said Siny Tsang, lead author on the study published in Frontiers in Neuroscience.

Tsang, a staff scientist with the WSU Elson S. Floyd College of Medicine, emphasised that this showed a connection, not a cause, but the study supports previous research that has found a two-way relationship between disrupted sleep patterns and poor mental health. In other words, when people do not sleep well, they are more likely to feel stress, anxiety and depression, and when they are dealing with those same problems, they are more likely to sleep less--and sometimes more--than the typical six to nine hours a night.

This study analyses survey responses collected between March 26 and April 5, 2020, from participants in the Washington State Twin Registry. Since then, the same group has answered three more waves of survey questions. Researchers are particularly interested in studying twins, so they can investigate whether associations are mediated by genetic factors, shared environment, or both. The pandemic also offered an opportunity for a natural experiment to see how a stressful situation affects sleep amount and quality among individuals in the community, Tsang said.

The research relies on the self-reported perception of sleep length and quality, but the researcher said that when it comes to mental health, perception can matter more than the real amount of sleep. "Even if your cell phone says you consistently sleep eight hours every day, you may feel that you slept less or slept poorly, and that may be linked to stressful or anxious feelings," Tsang said. "It may not matter whether or not the actual number has changed. It's how you are feeling that is associated with your mental health."

WSU researchers have also conducted twin studies on COVID-19 lockdown effects on alcohol use and pandemic stress and exercise. These have all been initial studies taken at the early stages of the pandemic and associated social distancing measures. The scientists are still analysing the results of later surveys, but they are starting to see a common theme. "A pattern that is consistent across these three studies is that people who reported change in physical exercise, alcohol use or sleep are more stressed, anxious and depressed than those who had said that they have had no change," Tsang said. (ANI)

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

The rest is here:
Depression, anxiety during pandemic linked to poor sleep - Devdiscourse

New research finds compound that blocks Covid-19 virus and protects lung cells – Hindustan Times

Research conducted at Louisiana State University Health New Orleans Neuroscience Center of Excellence reports that 'Elovanoids', bioactive chemical messengers made from omega-3 very-long-chain polyunsaturated fatty acids, may block the virus that causes Covid-19 from entering cells and protect the air cells (alveoli) of the lung.

The findings of the research are published in the journal Scientific Reports.

"Because the compounds are protective against damage in the brain and retina of the eye and the Covid-19 virus clearly damages the lung, the experiment tested if the compounds would also protect the lung," noted Nicolas Bazan, MD, PhD, Director of the LSU Health New Orleans Neuroscience Center and senior author of the paper.

The research team tested Elovanoids (ELVs) on infected lung tissue from a 78-year-old man in petri dish cultures. They found that ELVs not only reduced the ability of the SARS-CoV-2 spike protein to bind to receptors and enter cells, but they also triggered the production of protective, anti-inflammatory proteins that counteract lung damage.

The scientists report that ELVs decreased the production of ACE2. ACE2 is a protein on the surface of many cell types. ACE2 receptors act like locks on cells, and the SARS-CoV-2 spike proteins act like keys that open the locks letting the virus enter cells to multiply rapidly. They also demonstrated for the first time that alveolar cells are endowed with pathways for the biosynthesis of ELVs.

"Since SARS-CoV-2 affects nasal mucosa, the GI tract, the eye, and the nervous system, uncovering the protective potential of ELVs expands the scope of our observations beyond the lung. Our results provide a foundation for interventions to modify disease risk, progression, and protection of the lung from Covid-19 or other pathologies (including some types of pneumonia)," added Dr Bazan.

Follow more stories on Facebook and Twitter

See the original post here:
New research finds compound that blocks Covid-19 virus and protects lung cells - Hindustan Times

Men: Know Your Genetics to Lower Your Cancer Risk and That of Your Family – Baptist Health South Florida

A gene mutation that could put you at higher risk for cancer is just as likely to come from your father as your mother. Unfortunately, only 4 percent of those undergoing hereditary cancer gene testing are male, leaving a huge gap in the knowledge that could help you avoid cancer altogether or inform treatment decisions, according to a study published in the journal JAMA Oncology.

Louise Morrell, M.D., a genetics specialist and medical director of Lynn Cancer Institute at Boca Raton Regional Hospital, part of Baptist Health.

Men do not often seek testing and many times do not understand the importance of the information, saysLouise Morrell, M.D., a genetics specialist and medical director of Lynn Cancer Institute at Boca Raton Regional Hospital, part of Baptist Health. The more accurate our information, the better our guidance on prevention. In genetics, unlike other areas, the benefit extends to family members and perhaps for generations to come.

Inherited Cancers

Today, up to 15 percent of cancers are tied to a hereditary link. Knowing about those links may help you and other members of your family prevent or reduce the risk of cancer.

Scientists have identified many mutations that increase the risk for breast and gynecologic cancers, some prostate cancers, colon cancer, gastro-intestinal cancers, kidney cancer and more. For example, a man with prostate cancer tied to aBRCA2mutation, could pass that mutation to his son or daughter, increasing the risk of breast cancer in both children and of prostate cancer in the son.

Raising awareness of the value ofgenetic assessmentandtesting, particularly among men, is important to the experts atLynn Cancer InstituteandMiami Cancer Institute. Because the field of genetics moves at a rapid pace, discoveries may impact everything from guidelines for cancer screenings to treatment options for those who have cancer.

Although researchers have worked for decades on uncovering the links between genetic mutations and cancer, public knowledge grew when actress Angelina Jolie had her breasts removed in 2013, and then her ovaries in 2015, because she carried theBRCA1 gene mutation that is linked to a higher risk of breast and ovarian cancer. Ms. Jolies mother, grandmother and aunt had died from cancer, and her decision to prophylactically remove her breasts, ovaries and fallopian tubes to lower her cancer risk came after multiple tests and conversations with experts. The sameBRCA1andBRCA2mutations that raise the risk of breast cancer in women, also raise the odds of breast cancer in men by eight times, according to the American Cancer Society.

Ask Questions

Arelis Mrtir-Negrn, M.D., medical geneticist and head of the Clinical Genetics program at Miami Cancer Institute, part of Baptist Health.

Whether you are a man or a woman, your familys health history may be the key to your future, saysArelis Mrtir-Negrn, M.D., medical geneticist and head of the Clinical Genetics program at Miami Cancer Institute. Because as many men pass down mutations as women, you should be as aware of your fathers familys cancer history as your mothers. Know your family history. Ask questions. In general, the earlier cancer is caught, the better the chance of survival.

Like Ms. Jolie, when Matthew Knowles, the father of artists Beyonc and Solange, announced he had breast cancer in 2019, he put the spotlight on genetics. His mother, aunt and great aunt had died from breast cancer and he learned his rare male breast cancer was caused by aBRCA2 gene mutation. He understood that his daughters had a 50 percent chance of inheriting his mutation.

Genetic testing among Blacks is much lower than other races. Physicians would like that to change, particularly since some breast cancers that have a poorer prognosis also have a higher incidence in Black women. Fortunately, subsequent testing showed neither daughter had the mutation. Mr. Knowles underwent a mastectomy.

Thinking of genetics as a recipe may help some people better understand, genetic counselors say. All people inherit two copies of each gene: one from their mother and one from their father. Variations in genes are normal and are what give us our diversity. A slight change in the recipe may not make much of a difference but the wrong ingredient or too much or too little of something may cause the recipe to change drastically. In addition, not all mutations carry the same risk.

ABRCAmutation might lead to an 80 percent risk of breast cancer but anATMmutation might have a 20 percent lifetime risk, Dr. Morrell says. These are very different, which is why having this information is so valuable.

Its important to note that just because you carry a mutation doesnt mean you will get cancer. There are many things we take into account when we assess risk, Dr. Mrtir-Negrn says. We can suggest lifestyle modifications that could lower their chances of getting cancer. There are times when we might also suggest medications or present the idea of preventive surgery.

The genetic teams at Lynn Cancer Institute and Miami Cancer Institute offer multidisciplinary care to patients and often their family members who may also be affected to better understand their risks, help them determine if genetic testing would be beneficial, and assist them with understanding the results, whether they are positive, negative or inconclusive. The team also develops personalized cancer prevention for previvors, the term used for those with a predisposition to cancer.

Fortunately, technological advances continue to make it possible to test for more genes. In recent years, improvements have sped up testing and made it less expensive. In addition, in someone already diagnosed with cancer, the answers from genetic testing can help drive treatment and surgery decisions.

Who Should Consider Cancer Genetic Assessment?

Men should consider assessment if they:

Couples who have a family history of cancer and are considering pregnancy also frequently take advantage of genetic assessment. If you really want to be able to tell your children they are not at risk to have a particular mutation, you need to test both parents, Dr. Morrell says. The offspring can only inherit a mutation that the parents have. Mutations do not skip generations. The parent has to also inherit it.

For more information on genetic assessment, testing and counseling at the Morgan Pressel Center for Cancer Genetics at Lynn Cancer Institute, clickhere; for information on Miami Cancer Institutes Clinical Genetics program, clickhere.

Tags: genetic testing, Lynn Cancer Institute, Miami Cancer Institute

Original post:
Men: Know Your Genetics to Lower Your Cancer Risk and That of Your Family - Baptist Health South Florida

Free genetic testing offered to propel medical research, All of Us program building most diverse database – KLAS – 8 News Now

LAS VEGAS (KLAS) The National Institutes of Health (NIH) All of Us Research Program is offering no-cost genetic testing, just in time for Fathers Day.

The free genetic testing kit offers a unique opportunity to discover your ancestral past and learn more about your own health.

By participating in the NIH program, researchers will be able to study your results in hopes of better understanding how certain genetic traits affect underrepresented communities, which could greatly affect the future of customized healthcare.

Matthew Thombs, Senior Project Manager of Digital Health Technology at Scripps Research walked 8NewsNow through what participants would experience when they sign up for the study. He also explained why he is proud to be a part of the All of Us Research Program:

I joined the All of Us Research Program a little over a year ago and have fallen in love with its mission of creating the largest and most diverse health resource ever. I lost a close family member a few years ago to a condition I believe could have been managed with changes to their lifestyle. What we are building will empower researchers with the information needed to make such conclusions and forever alter how diseases are treated. I hope that what we are doing here will help my son grow up in a world where health care is more of a priority and many of the ailments we seetodayare things of the past.

You can sign up for the program online or by downloading the All of Us mobile application from the iOS or Android app store. Once you open the application, you would create a personal profile, sign the necessary consent forms and decide if you would also like to receive a salivary kit. The test kit would be mailed to you free of charge, and include a pre-paid mailing label to return your sample.

MOVING AWAY FROM ONE-SIZE-FITS ALL HEALTH CARE

Thombs says a fun aspect of TheAll of UsResearch Program is learning more about traits that may have been passed down to you. Can you roll your tongue like your father? Does caffeine sensitivity run in your family?

You may even discover that you need to modify or remove something from your diet to improve your health or help you feel better. Your test kit results provide you with information on what makes you you.

The information collected is also shared anonymously with more than 800 researchers in search of medical discoveries for COVID-19, Alzheimers, Cancer, and other conditions.

INVITATION JOIN THE RESEARCH PROGRAM

Thombs says The All of Us Research Program is working to build a diverse community of one million or more participants across the country to help researchers learn more about how genetics, environment and lifestyle affect individuals health, especially those in communities who have largely been left out of these kinds of research programs.

We want to be able to propel research forward, said Thombs.

Perhaps your genetic makeup allows you to recover from certain ailments and return to excellent health. That data is valuable and can help someone whose body struggles with the same illness. To understand how humans function and what makes us sick, all human beings need to be included in research studies.

According to Thombs, participants can provide as much or as little information as they like, every single data point matters.

Feel free to visit the All of US website at http://www.joinallofus.org/health for more information.

Read the original:
Free genetic testing offered to propel medical research, All of Us program building most diverse database - KLAS - 8 News Now

Giles Yeo: Lets consider the type of food we eat, not fixate on calories – The Guardian

Since the dawn of the 20th century, almost all weight loss guidelines have used calories as a simple measure of how much energy were consuming from our food. But according to Giles Yeo, a Cambridge University research scientist who studies the genetics of obesity, theres one problem: not all calories are created equal. In his new book, Why Calories Dont Count, Yeo explains that what really matters is not how many calories a particular food contains, but how that food is digested and absorbed by your body.

Can you explain why you feel calorie-counting is a flawed approach to weight loss?There was an American chemist in the 19th century called Wilbur Olin Atwater who calculated the calorie numbers for different foods, by working out the total energy intake you get from them. But his calculations never took into account the energy it takes our cells to metabolise food in order to use it. This is important. Its why for example a calorie of protein makes you feel fuller than a calorie of fat, because protein is more complex to metabolise. For every 100 calories of protein you eat, you only ever absorb 70.

So we need to consider the type of food were eating, rather than fixating purely on the calorie content. You could be aiming to eat 800 calories a day, but how much energy your body actually absorbs will depend on whether youre eating sugar, celery, or steak.

How could people use this information practically when trying to manage their weight?What really annoys me is when weight loss gurus say things like: Oh, just replace the chocolate bar with a banana. Now thats a dumb thing to say, because sometimes life demands a banana, and sometimes life demands a chocolate bar.

But you can make a better practical choice in those situations by considering how the body processes food. It takes a lot longer to digest food elements like protein and fibre, so you absorb less of those calories, so if you choose a chocolate bar thats higher in nuts or dry fruits, that will make it a better chocolate bar.

Speaking of more nuanced approaches to managing weight, recently, body mass index has come under fire as being an inherently flawed measure of obesity. Is it still appropriate for doctors to use BMI?I would define an obese person as someone who is carrying too much fat, so that it begins to influence their health. But then the question is, how much is too much fat? Your fat cells are like balloons, they get bigger when you gain weight, they shrink when you lose weight. But everyones fat cells expand and contract to different amounts, so everybody has a different safe, fat-carrying capacity. Famously, us east Asians cannot get too big BMI-wise before we increase our risk of diseases such as type 2 diabetes, because we have a lower safe fat-carrying capacity.

BMI is very useful for looking at population trends, because its free to measure, and you only need your height and weight. But at an individual level, this is not useful to predict health because it doesnt take into account genetic and ethnic differences in fat capacity. You could be a rugby player, or the same size as a rugby player, and be all fat, and yet have the same BMI. So I think healthcare professionals need to consider the whole, rather than simply BMI itself.

The FDAs approval of semaglutide the first new drug to be approved for obesity since 2014 has made a lot of headlines this year. Is obesity something we should be treating with drugs?I see it as being part of the toolkit. A lot of people consider obesity as a lifestyle disease; they perceive that being larger than someone else comes down to choice, when this is not the case. For many people, its more difficult to say no to food purely because of their genetics.

Semaglutide makes your brain think youre slightly fuller than you are, so you eat less, and if someone is finding it difficult to lose weight, why not use it? Im not countenancing drugging the entire population, but I think semaglutide should be one of the tools we use, alongside lifestyle intervention, exercise, all of those things.

You research genetic factors that control susceptibility to obesity. What do these genes do?We now know that more than 1,000 genes are linked to obesity, and the vast majority of them influence pathways in three different parts of the brain that ultimately influence your feeding behaviour. One is the brains fuel sensor called the hypothalamus, then theres the part of the brain that senses how full you get, and then theres the hedonic part of the brain that makes eating feel good. All of these regions speak to one another, and some of these 1,000 genes influence these pathways. A mutation that causes a slight insensitivity in your brain to how full you are could influence how much you want to eat, making it more difficult to say no to temptations.

For example, we know that one in 330 people in the UK have mutations in a particular pathway called the leptin-melanocortin pathway, which renders your brain slightly less sensitive to how much fat youre carrying.

Will we be able to use our genetic knowledge of obesity to develop new treatments that regulate appetite?Yes, theres now a drug called setmelanotide, which targets the leptin-melanocortin pathway. It has just been approved in the US for rare genetic causes of obesity, and the European Medicines Agency should be approving it within weeks. Eventually it will be trialled in the larger population, much like semaglutide was, to see whether you can fool your brain into thinking that youre carrying more fat, and so you end up eating less. This is an example of how understanding the basic biology of obesity, the wiring, the genes involved, can result in cogent and hopefully sustainable ways of tackling it.

In your book, you touch on how obesity isnt solely genetic, and factors such as socioeconomic status play a key role in determining how those genes are expressed, and how much they matter.The heritability of body weight the percentage of the trait that is down to your genes is a range, which lies somewhere between 40 and 70%.

A colleague of mine, Professor Clare Llewellyn at UCL, has a twin cohort called the Gemini study, where shes looked at the role of socioeconomic status on body weight. Shes shown that if you take middle-class families, the heritability of their body weight is roughly around the 40% mark. But you go to households with the lowest socioeconomic class, and the highest levels of food insecurity, suddenly it jumps to 70%.

Genetically, theres no difference between people who are poorer and those who are richer its an accident of birth. But because of your socioeconomic situation, your risk of obesity can jump from 40% to 70%. It shows that if we manage to cure poverty, childhood poverty in particular, we can drop the heritable risk of obesity from 70% to 40% without even touching the biology of the system.

Exercise has been getting a bad rep for its weight loss powers. Is that really deserved? You run a lot: are you doing that to keep trim or for other reasons?In and of itself, exercise is not effective for weight loss. It is in principle possible to lose weight through exercise Tour de France cyclists eat at least 5,000 calories a day and still lose weight during the three-week race. The problem is most of us mere mortals dont exercise anywhere near enough for this to be effective. It is, however, useful for weight maintenance after you have achieved weight loss. So I stay active on my bike and running, to stay fit, but also to maintain my weight.

Why Calories Dont Count by Giles Yeo is published by Orion (14.99). To support the Guardian and Observer order your copy at guardianbookshop.com. Delivery charges may apply

Read this article:
Giles Yeo: Lets consider the type of food we eat, not fixate on calories - The Guardian

The sequencing of genetic material is a powerful conservation tool – The Economist

Jun 15th 2021

IN SEPTEMBER AND October 2000, the carcasses of several northern hairy-nosed wombats and some fragments of intestine were discovered in Australias Epping Forest National Park, apparently left behind by a mystery predator. Cattle farming has shrunk the wombats natural habitat and consequently their population, which reached a low of just 20-30 animals in the 1970s before land-management policies helped push numbers back up to roughly 100 in the early 2000s. By sequencing DNA extracted from the Epping Forest remains, researchers identified six males and one female. But what had slain 6% of the known wombat population?

Your browser does not support the

Enjoy more audio and podcasts on iOS or Android.

Suspicion fell on either dingoes or wild dogs, and the final answer came packaged inside faeces collected in the park. Some yielded the same genetic sequences as the carcasses. They had been left by dingoes. The team had identified their killers, and in 2002 a 20km protective fence was put up around the forest.

Environmental DNA, or eDNA, has emerged as an increasingly popular tool among conservation biologists and land managers, as DNA-sequencing tools have become progressively smaller, faster and cheaper. The field began in the late 1980s, when microbiologists started using it to look for bacteria in rivers and sediment. This had previously involved smearing water or dirt on Petri dishes to grow colonies of the resident microbes and then identifying them under the microscope, based on the shape of the colonies or how they responded to being stained with dye. It was lengthy and error-prone. Extracting DNA from samples instead, and comparing their genetic sequence to reference libraries, was quicker and more reliable.

The same approach was adopted and built upon in the early 2000s by ecologists, who were aware that the animals they studied were constantly shedding DNA in faeces, saliva, blood, scales and sloughed tissue. Gathering and sequencing this material provided valuable information without needing to interact with the animals themselves. The approach found particular favour early on with researchers studying freshwater systems. By simply dipping a test tube into a stream, they could find out if a target species was present and even how abundant it was.

Because trace amounts of DNA can be amplified before sequencing using a method called polymerase chain reaction (PCR, the same method used to detect SARS-CoV-2 in coronavirus testing), eDNA studies can detect species present in low numbersa useful tool for tracking down rare species, or spotting invasive ones before they wreak havoc on a fishery. Other studies have sought evidence that escapees from fish farms were mating with wild populations, potentially eroding them.

DNA from scat, as wild animal droppings are known, can map out food chains without having to capture and kill animals in order to examine the contents of their guts. Killing large or rare species like whales, even for conservation purposes, poses ethical and practical challenges. But whale scat has the great advantage of buoyancy. Finding a turd floating in the middle of the ocean is made easier with the help of dogs that are trained to sniff out the signature smells of excrement belonging to a range of endangered species. DNA in the netted excrement can be analysed to determine what the animal ate, or what bacteria live in its gut.

On land, researchers can use eDNA from faeces, urine or hair to see how populations are interacting. In Malaysia, an ongoing project is focused on whether sub-populations of the Malayan tiger are still connected when deforestation has fragmented their habitat. In Britain eDNA is used to monitor a protected newt. Other projects have begun to show that cells left in footprints in snow can yield enough DNA to identify species and possibly sex.

Several groups are attempting to identify all the individuals belonging to a population from footprint DNA, which would transform monitoring of populations, help with the tracking of animals as they roam across wide areas without the need for radiotags, and setting sustainable hunting quotas. Researchers at the US Forest Service are trying this with wolves.

So-called metagenomic studies use e DNA to map the genetic make-up of entire communities, such as coral reefs, or the vast, largely unexplored bacterial community that lives deep inside the Earths crust and whose biomass is an order of magnitude greater than that of all animals combined. Such studies can offer a genetic snapshot that might take years of field studies to establish.

The field is booming, but there are challenges. It can be difficult to tell when eDNA was deposited. DNA sampled at one point in a river could have come from anywhere upstream. And species identification is only as good as the species-specific genetic barcodes and reference genomes that serve as points of comparison. This has spurred a rush of projects to either identify a unique genetic signature for every species, such as the International Barcode of Life, or sequence the whole genomes of as many species as possible (see chart). The $4.7bn Earth Biogenome Project aims to sequence 1.5m species in ten years. As well as collecting and preserving genomes, such genetic databases can be mined for information on susceptibility to disease, or for potential medicines.

But even though genetic sequencing has become much cheaper since the late 20th century, it remains prohibitively expensive for most researchers outside America, Europe and China. Sequencing technologies are improving rapidly, however. In particular, Oxford Nanopore, a British company, has developed portable technology that allows sequencing to be done in the field, not just in the lab. It relies on nanopore sequencing, a technique in which strands of DNA are drawn through a nanometre-sized pore in a biological membrane. Each of the four letters of the DNA alphabet produces a distinct electrical signal as it passes through the pore, allowing the sequence to be read in real time.

Oxford Nanopores Min ION, a USB-powered, pocket-sized device, allows every part of the sequencing process to be done in the field. Sequences are produced within an hour. The devices are relatively affordable: prices start at around $1,000, though subsequent recharges are needed to run more samples. They have been used to sequence viruses in Brazil, amphibian DNA in Tanzania and bacteria on the International Space Station.

The technology also opens up new possibilities for investigation and enforcement. Genetic sequencing in the field can be used to identify the nature and origin of illegal bushmeat, fish or smuggled ivory. A paper published in Forensic Science International: Genetics in March 2021 compared results obtained by the Min ION with the standard sequencing methods used in wildlife forensics. It found the results to be comparable, potentially paving the way for handheld devices to be used in wildlife-crime prosecutions.

Full contents of this Technology QuarterlyThe other environmental emergency: Loss of biodiversity poses as great a risk to humanity as climate changeSensors and sensibility: All kinds of new technology are being used to monitor the natural world* Cracking the code: The sequencing of genetic material is a powerful conservation toolCrowdsourced science: How volunteer observers can help protect biodiversitySimulating everything: Compared with climate, modelling of ecosystems is at an early stageBack from the dead: Reviving extinct species may soon be possibleBridging the gap: Technology can help conserve biodiversity

This article appeared in the Technology Quarterly section of the print edition under the headline "Cracking the code"

Read the original here:
The sequencing of genetic material is a powerful conservation tool - The Economist